secwatch.observer — SEC 8-K summary
======================================

Issuer:     RetinalGenix Technologies Inc. (RTGN)
CIK:        0001836295
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0001493152-23-043870
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

RetinalGenix appoints Dr. Dessislava Boneva as director
-------------------------------------------------------

- Dr. Boneva appointed to board effective December 4, 2023.
- She is a trauma surgeon with board certifications in surgery and surgical critical care.
- No family relationships or material interests with company executives.
- Serves as Surgery Clerkship Director/Clinical Assistant Professor at Nova Southeastern University.
- Fellow of American College of Surgeons with 20+ years of experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1836295/000149315223043870/0001493152-23-043870-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1836295/000149315223043870/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043870

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer